160 related articles for article (PubMed ID: 27676678)
1. Evaluation of Bone Cancer Pain Induced by Different Doses of Walker 256 Mammary Gland Carcinoma Cells.
Dong C; Wu R; Wu J; Guo J; Wang F; Fu Y; Wang Q; Xu L; Wang J
Pain Physician; 2016; 19(7):E1063-77. PubMed ID: 27676678
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats.
Wang J; Zhang R; Dong C; Jiao L; Xu L; Liu J; Wang Z; Mao Ying QL; Fong H; Lao L
J Ethnopharmacol; 2012 Oct; 143(3):905-13. PubMed ID: 22960543
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.
Lu C; Liu Y; Sun B; Sun Y; Hou B; Zhang Y; Ma Z; Gu X
Inflammation; 2015 Oct; 38(5):1880-90. PubMed ID: 25896633
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA Exerts an Antinociceptive Effect in Rats with Cancer-induced Bone Pain.
Hao W; Chen L; Wu LF; Yang F; Niu JX; Kaye AD; Xu SY
Pain Physician; 2016; 19(7):465-76. PubMed ID: 27676663
[TBL] [Abstract][Full Text] [Related]
6. Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain.
Tong W; Wang W; Huang J; Ren N; Wu SX; Li YQ
Biochem Biophys Res Commun; 2010 May; 395(4):572-6. PubMed ID: 20399746
[TBL] [Abstract][Full Text] [Related]
7. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms.
Liu S; Yang J; Wang L; Jiang M; Qiu Q; Ma Z; Liu L; Li C; Ren C; Zhou J; Li W
Brain Res; 2010 Jul; 1346():213-23. PubMed ID: 20478276
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic characterisation of the optimised rat model of Walker 256 breast cancer cell-induced bone pain.
Shenoy PA; Kuo A; Leparc G; Hildebrandt T; Rust W; Nicholson JR; Corradini L; Vetter I; Smith MT
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1201-1215. PubMed ID: 31429474
[TBL] [Abstract][Full Text] [Related]
9. [The role of brain-derived neurotrophic factor in pain facilitation and spinal mechanism in rat model of bone cancer pain].
Wang LN; Yang JP; Ji FH; Wang XY; Zuo JL; Xu QN; Jia XM; Zhou J; Ren CG; Li W
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1188-92. PubMed ID: 21756773
[TBL] [Abstract][Full Text] [Related]
10. Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain.
Jiang J; Zhang J; Yao P; Wu X; Li K
Int J Oncol; 2014 Jul; 45(1):235-44. PubMed ID: 24818668
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model.
Yin Q; Cheng W; Cheng MY; Fan SZ; Shen W
Behav Pharmacol; 2010 Oct; 21(7):595-601. PubMed ID: 20736819
[TBL] [Abstract][Full Text] [Related]
12. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ
Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433
[TBL] [Abstract][Full Text] [Related]
13. Topical treatment with Xiaozheng Zhitong Paste alleviates bone cancer pain by inhibiting proteinase-activated receptor 2 signaling pathway.
Bao Y; Wang G; Gao Y; Du M; Yang L; Kong X; Zheng H; Hou W; Hua B
Oncol Rep; 2015 Sep; 34(3):1449-59. PubMed ID: 26133236
[TBL] [Abstract][Full Text] [Related]
14. P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
Chen J; Wang L; Zhang Y; Yang J
Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):367-72. PubMed ID: 22349022
[TBL] [Abstract][Full Text] [Related]
15. cGMP and cGMP-dependent protein kinase I pathway in dorsal root ganglia contributes to bone cancer pain in rats.
Liu S; Zhang MY; Chen LP; Liu YP; Liu GJ
Spine (Phila Pa 1976); 2014 Sep; 39(19):1533-41. PubMed ID: 24921837
[TBL] [Abstract][Full Text] [Related]
16. The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction.
Kim WM; Jeong CW; Lee SH; Kim YO; Cui JH; Yoon MH
Anesth Analg; 2011 Oct; 113(4):934-40. PubMed ID: 21788320
[TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Channel and Interleukin-17A Involvement in LTTL Gel Inhibition of Bone Cancer Pain in a Rat Model.
Wang J; Zhang R; Dong C; Jiao L; Xu L; Liu J; Wang Z; Lao L
Integr Cancer Ther; 2015 Jul; 14(4):381-93. PubMed ID: 26100378
[TBL] [Abstract][Full Text] [Related]
18. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells.
Mao-Ying QL; Zhao J; Dong ZQ; Wang J; Yu J; Yan MF; Zhang YQ; Wu GC; Wang YQ
Biochem Biophys Res Commun; 2006 Jul; 345(4):1292-8. PubMed ID: 16725112
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Spinal Bv8/Prokineticin 2 in a Rat Model of Cancer-Induced Bone Pain.
Hang LH; Luo H; Li SN; Shu WW; Chen Z; Chen YF; Yuan JF; Shi LL; Shao DH
Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):180-5. PubMed ID: 25641661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
